Skip to content

Clinical Study of Silicea 30, a Homoeopathic Medicine in Treatment of Rickets.

A Randomized Controlled Study Of Silicea Terra 30 A Homoeopathic Medicine As An Adjuvant In Children With Rickets

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041414
Enrollment
30
Registered
2022-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E550- Rickets, active

Interventions

Intervention1: Silicea Terra 3o: Silicea terra 30, 4 Pills of size 30, Orally STAT, Every 2 weeks for 3 Months. Duration - 3 months. All medicines will be procured from a Good Manufacturing Practice (

Sponsors

Bharati Vidyapeeth Deemed To Be University Homoeopathic Medical College and Hospital Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children below the age of 12 years of both sex. 2.Children with pre diagnosed rickets.

Exclusion criteria

Exclusion criteria: 1.Children above the age of 12 years. 2.Children with any history of tuberculosis. 3.Children with any other co-morbidities like malignancies, immunocompromised states,asthma etc. 4.Vhildren who did not come for the follow ups.

Design outcomes

Primary

MeasureTime frame
1.To assess the effect of silicea terra 30, a homoeopathic medicine in children with rickets by observing changes in rickets severity score(RSS) in radiograph, changes in Photographs and Serum Calcium, Serum Phosphorous Serum Alkaline Phosphatase and Vit D3 levels.Timepoint: To outcome of above mentioned parameters will be assessed and compared at Baseline,6 weeks, 10 weeks and 14 weeks.

Secondary

MeasureTime frame
1) To assess the effect in anthropometric measurements like -Height -Weight -Mid Arm Circumference -Head Circumference -Chest Circumference 2) To assess improvement in Generalities like appetite and activity Timepoint: To outcome 0f the above mentioned parameters will be assessed and compared at Baseline,2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks.

Countries

India

Contacts

Public ContactDr Swati R Shinde

Bharati Vidyapeeth (Deemed To Be) University Homoeopathic Medical College and Hospital.

swatishinde3316@gmail.com9890140393

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026